Therapeutic neutralizing monoclonal antibody administration protects against lethal viscerotropic Yellow Fever infection
M. J. Ricciardi, L. N. Rust, N. Pedreno-Lopez…·B. J. Burwitz
Therapeutic monoclonal antibodies prevent death from YFV infection.
Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
5 papers
Recent·Most cited
M. J. Ricciardi, L. N. Rust, N. Pedreno-Lopez…·B. J. Burwitz
Therapeutic monoclonal antibodies prevent death from YFV infection.
D. Haslwanter, G. Lasso, A. Z. Wec…·K. Chandran
This study shows that South American yellow fever virus strains are less susceptible to vaccine-induced antibodies due to genetic changes in the glycoprotein E.
A. Panganiban, R. V. Blair, J. B. Hattler…·W.-K. Kim
This study investigates ZIKV-induced neuropathy in adult macaques, finding chronic neuroinflammation, BBB disruption, and sustained CXCL12 upregulation in the CNS.
B. Schouest, M. Fahlberg, E. A. Scheef…·N. J. Maness
This study shows CD8+ lymphocytes control ZIKV dissemination and immune regulation in nonhuman primates by affecting viremia, tissue viral loads, and immune responses.
M. M. Gomez, F. V. S. de Abreu, A. A. C. dos Santos…·M. C. Bonaldo
The paper analyzes genomic and structural features of Yellow Fever virus from the 2016-2017 Brazilian outbreak, identifying unique amino acid substitutions in non-structural proteins that may affect viral fitness and transmissibility.